Announced details
Development of a treatment for idiopathic pulmonary fibrosis; respiratory and thoracic diseases
Joint research relationship aimed at developing a treatment for idiopathic pulmonary fibrosis using HGF protein
Kanazawa University's respiratory medicine and respiratory medicine departments. Professor Seiji Yano (矢野 聖二), Specially Appointed Associate Professor Satoshi Watanabe (渡辺 知志), and others are listed as joint researchers. Other information, including location, capital, year established and business description, is Not disclosed.
Orlando, Florida, United States (conference venue)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Golchin et al. Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis. BMC Pulmonary Medicine (2025) 25:378. Official conference website: https://site.thoracic.org/conference
| Item | Details |
|---|---|
| Names of Products / Services Covered | Development of a treatment for idiopathic pulmonary fibrosis using HGF protein (Hepatocyte Growth Factor) |
| Counterparty | Department of Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences / Department of Respiratory Medicine, Kanazawa University Hospital; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kanazawa University / Department of Respiratory Medicine, Kanazawa University Hospital |
| Counterparty overview | Kanazawa University's respiratory medicine and respiratory medicine departments. Professor Seiji Yano (矢野 聖二), Specially Appointed Associate Professor Satoshi Watanabe (渡辺 知志), and others are listed as joint researchers. Other information, including location, capital, year established and business description, is Not disclosed. |
| Relationship with the Company | Joint research relationship aimed at developing a treatment for idiopathic pulmonary fibrosis using HGF protein |
| Applicable area | Development of a treatment for idiopathic pulmonary fibrosis; respiratory and thoracic diseases |
| Location | Orlando, Florida, United States (conference venue) |
| Source | Golchin et al. Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis. BMC Pulmonary Medicine (2025) 25:378. Official conference website: https://site.thoracic.org/conference |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To obtain insights and engage in discussions with international researchers and clinicians, clarify the role of HGF in idiopathic pulmonary fibrosis, and apply the findings to future research development and expansion of indications.